ABRILADA™ (adalimumab-afzb) Pen
ABRILADA™ (adalimumab-afzb) Pen is Pfizer’s citrate-free adalimumab biosimilar that is interchangeable with Humira. *
The ABRILADA Pen is citrate-free and offers out-of-refrigerator stability for up to 30 days. Visit ABRILADA
*ABRILADA is interchangeable for the indications of use, dosage forms, strengths and routes of administration described in Prescribing Information.
Arthritis.org is neither owned nor controlled by Pfizer. Pfizer does not endorse and is not responsible for the content or services of the site.
Ease of Use Program
Products Proven to Make Life Easier
The Arthritis Foundation's Ease of Use Certification Program recognizes products proven to make life easier for people who have arthritis and other physical limitations. Independently tested by experts and evaluated by people with arthritis, Ease of Use products are easy to use for everyone.
Learn More About the Ease of Use Program